Personalis Inc (PSNL)

$6.24 -0.10 (-1.58%)
Market Cap 663.37M
Revenue (ttm) 69.65M
Net Income (ttm) -81.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -116.68%
Debt to Equity Ratio 0.00
Volume 1,369,867
Avg Vol 1,504,946
Day's Range N/A - N/A
Shares Out 104.63M
Stochastic %K 5%
Beta 2.02
Analysts Strong Sell
Price Target $11.43

Company Profile

Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome sequencing data with advanced analytics to provide a multi-dimensional view of the tumor an...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 650 752 1300
Fax: 650 752 1301
Address:
6600 Dumbarton Circle, Fremont, United States
ExNoose
ExNoose Mar. 30 at 3:04 PM
$PSNL Uptrend still in tact.
0 · Reply
arribaStocktrading
arribaStocktrading Mar. 30 at 2:50 PM
$PSNL Falling NAZ creates a tough trading environment. (Blue Line is the NASDAQ's break-even line for the year) Personalis has to be pretty close to its bottom. I bought quite a bit on Friday.
1 · Reply
BioTechNoir
BioTechNoir Mar. 30 at 2:39 PM
$PSNL nibbled
1 · Reply
LordBrypto
LordBrypto Mar. 30 at 1:51 PM
$PSNL can the pain and suffering stop
1 · Reply
magnitudeFC
magnitudeFC Mar. 30 at 2:21 AM
$PSNL can anyone here talk me out of making PSNL a 70% position? I'm pretty close to doing it.
3 · Reply
ExNoose
ExNoose Mar. 29 at 12:43 PM
$PSNL Cathie Wood: The most underestimated place for AI innovation is healthcare! - AI will diagnose cancer from blood tests before symptoms appear - Pharma faces a $300B patent cliff in the next 5 years - That fear and caution is exactly where the opportunity is High conviction in PSNL.
3 · Reply
ExNoose
ExNoose Mar. 28 at 4:57 AM
$PSNL We just love dramatic daily drops!
0 · Reply
GGator
GGator Mar. 27 at 10:34 PM
$PSNL Hey, look around. Almost every stock is getting whacked. I know this sucks. The downside will be more pronounced here. But it will also be more pronounced on the other side if they continue executing when we come out of this. Just a thought. Have a great weekend all.
0 · Reply
magnitudeFC
magnitudeFC Mar. 27 at 8:02 PM
$PSNL Good news and data.. sounds about right for a 15% chop! https://x.com/PersonalisInc/status/2037612942628434274?s=20
1 · Reply
arribaStocktrading
arribaStocktrading Mar. 27 at 7:43 PM
$PSNL Sir, I'm tired of winning. Can we please stop winning so much!
2 · Reply
Latest News on PSNL
Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption

Mar 17, 2026, 4:00 PM EDT - 13 days ago

Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption

Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal®

Mar 12, 2026, 6:00 AM EDT - 18 days ago

Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal®

Personalis, Inc. (PSNL) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 11:37 PM EST - 4 weeks ago

Personalis, Inc. (PSNL) Q4 2025 Earnings Call Transcript

Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights

Feb 26, 2026, 4:01 PM EST - 4 weeks ago

Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights

Personalis to Participate in the TD Cowen 46th Annual Healthcare Conference

Feb 17, 2026, 4:01 PM EST - 5 weeks ago

Personalis to Participate in the TD Cowen 46th Annual Healthcare Conference

Personalis to Announce Fourth Quarter and Full Year 2025 Financial Results

Feb 12, 2026, 4:01 PM EST - 6 weeks ago

Personalis to Announce Fourth Quarter and Full Year 2025 Financial Results

Personalis Receives Medicare Coverage for NeXT Personal® in Lung Cancer Surveillance

Feb 10, 2026, 6:00 AM EST - 6 weeks ago

Personalis Receives Medicare Coverage for NeXT Personal® in Lung Cancer Surveillance

Personalis Announces New Publication Expanding Evidence for Ultrasensitive ctDNA Monitoring of Cancer Immunotherapy Response Across Solid Tumors

Feb 2, 2026, 6:00 AM EST - 2 months ago

Personalis Announces New Publication Expanding Evidence for Ultrasensitive ctDNA Monitoring of Cancer Immunotherapy Response Across Solid Tumors

Personalis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Jan 28, 2026, 4:01 PM EST - 2 months ago

Personalis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™

Jan 12, 2026, 4:00 PM EST - 2 months ago

Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™

Personalis Reports Select Preliminary Fourth Quarter and Full Year 2025 Results and Recent Highlights

Jan 8, 2026, 8:00 AM EST - 2 months ago

Personalis Reports Select Preliminary Fourth Quarter and Full Year 2025 Results and Recent Highlights

Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors

Dec 17, 2025, 6:00 AM EST - 3 months ago

Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors

New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer

Dec 11, 2025, 9:00 AM EST - 3 months ago

New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer

Personalis to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 4:01 PM EST - 4 months ago

Personalis to Participate in the Piper Sandler 37th Annual Healthcare Conference

Personalis Announces Medicare Coverage for Ultrasensitive MRD Test in Breast Cancer

Nov 10, 2025, 9:00 AM EST - 5 months ago

Personalis Announces Medicare Coverage for Ultrasensitive MRD Test in Breast Cancer

Personalis, Inc. (PSNL) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 9:46 PM EST - 5 months ago

Personalis, Inc. (PSNL) Q3 2025 Earnings Call Transcript

Personalis Reports Third Quarter 2025 Financial Results

Nov 4, 2025, 4:01 PM EST - 5 months ago

Personalis Reports Third Quarter 2025 Financial Results

Personalis to Announce Third Quarter 2025 Financial Results

Oct 21, 2025, 4:01 PM EDT - 5 months ago

Personalis to Announce Third Quarter 2025 Financial Results

Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing

Oct 16, 2025, 9:00 AM EDT - 5 months ago

Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sep 15, 2025, 5:35 PM EDT - 6 months ago

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CATE Clinical Trial Launched to Demonstrate the Clinical Utility of ctDNA-Guided Treatment in Breast Cancer Using the Ultrasensitive NeXT Personal Test

Sep 10, 2025, 4:05 PM EDT - 7 months ago

CATE Clinical Trial Launched to Demonstrate the Clinical Utility of ctDNA-Guided Treatment in Breast Cancer Using the Ultrasensitive NeXT Personal Test

Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing

Sep 3, 2025, 4:05 PM EDT - 7 months ago

Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing

Personalis to Participate in Upcoming Investor Conferences

Aug 27, 2025, 4:01 PM EDT - 7 months ago

Personalis to Participate in Upcoming Investor Conferences

Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Aug 6, 2025, 8:11 AM EDT - 8 months ago

Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

SMCI

Personalis, Inc. (PSNL) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 10:49 PM EDT - 8 months ago

Personalis, Inc. (PSNL) Q2 2025 Earnings Call Transcript

Personalis Reports Second Quarter 2025 Financial Results

Aug 5, 2025, 4:01 PM EDT - 8 months ago

Personalis Reports Second Quarter 2025 Financial Results

Personalis to Announce Second Quarter 2025 Financial Results

Jul 22, 2025, 4:01 PM EDT - 8 months ago

Personalis to Announce Second Quarter 2025 Financial Results

Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients

Jul 9, 2025, 4:00 PM EDT - 9 months ago

Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients

TEM

Personalis' NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO

Jun 3, 2025, 4:00 PM EDT - 10 months ago

Personalis' NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO

New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse

Jun 2, 2025, 4:00 PM EDT - 10 months ago

New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse

Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection

May 22, 2025, 6:00 AM EDT - 11 months ago

Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection

Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference

May 14, 2025, 4:01 PM EDT - 11 months ago

Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference

Personalis, Inc. (PSNL) Q1 2025 Earnings Call Transcript

May 6, 2025, 8:41 PM EDT - 11 months ago

Personalis, Inc. (PSNL) Q1 2025 Earnings Call Transcript

Personalis Reports First Quarter 2025 Financial Results

May 6, 2025, 4:01 PM EDT - 11 months ago

Personalis Reports First Quarter 2025 Financial Results

Personalis' NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study

Apr 28, 2025, 5:00 PM EDT - 1 year ago

Personalis' NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study

Personalis to Announce First Quarter 2025 Financial Results

Apr 22, 2025, 4:01 PM EDT - 1 year ago

Personalis to Announce First Quarter 2025 Financial Results

Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection

Apr 22, 2025, 6:00 AM EDT - 1 year ago

Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection

Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference

Mar 26, 2025, 4:01 PM EDT - 1 year ago

Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference

New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection

Mar 3, 2025, 6:00 AM EST - 1 year ago

New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection

Personalis, Inc. (PSNL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 7:40 PM EST - 1 year ago

Personalis, Inc. (PSNL) Q4 2024 Earnings Call Transcript

Personalis Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 27, 2025, 4:01 PM EST - 1 year ago

Personalis Reports Fourth Quarter and Full Year 2024 Financial Results

3 Biotech/Healthcare Names Under $10 I Am Buying Now

Feb 21, 2025, 4:21 PM EST - 1 year ago

3 Biotech/Healthcare Names Under $10 I Am Buying Now

ARDX GERN MRNA TEM

Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference

Feb 18, 2025, 4:01 PM EST - 1 year ago

Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference

Exciting Technology At Personalis, But Profitability Eludes Them

Feb 14, 2025, 10:50 AM EST - 1 year ago

Exciting Technology At Personalis, But Profitability Eludes Them

Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results

Feb 13, 2025, 4:01 PM EST - 1 year ago

Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results

Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Jan 28, 2025, 4:01 PM EST - 1 year ago

Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer

Jan 13, 2025, 5:00 AM EST - 1 year ago

New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer

Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue

Jan 7, 2025, 4:01 PM EST - 1 year ago

Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue

Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna

Dec 19, 2024, 9:00 AM EST - 1 year ago

Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna

Personalis and Tempus Expand Collaboration to Biopharma

Dec 16, 2024, 8:00 AM EST - 1 year ago

Personalis and Tempus Expand Collaboration to Biopharma

TEM

ExNoose
ExNoose Mar. 30 at 3:04 PM
$PSNL Uptrend still in tact.
0 · Reply
arribaStocktrading
arribaStocktrading Mar. 30 at 2:50 PM
$PSNL Falling NAZ creates a tough trading environment. (Blue Line is the NASDAQ's break-even line for the year) Personalis has to be pretty close to its bottom. I bought quite a bit on Friday.
1 · Reply
BioTechNoir
BioTechNoir Mar. 30 at 2:39 PM
$PSNL nibbled
1 · Reply
LordBrypto
LordBrypto Mar. 30 at 1:51 PM
$PSNL can the pain and suffering stop
1 · Reply
magnitudeFC
magnitudeFC Mar. 30 at 2:21 AM
$PSNL can anyone here talk me out of making PSNL a 70% position? I'm pretty close to doing it.
3 · Reply
ExNoose
ExNoose Mar. 29 at 12:43 PM
$PSNL Cathie Wood: The most underestimated place for AI innovation is healthcare! - AI will diagnose cancer from blood tests before symptoms appear - Pharma faces a $300B patent cliff in the next 5 years - That fear and caution is exactly where the opportunity is High conviction in PSNL.
3 · Reply
ExNoose
ExNoose Mar. 28 at 4:57 AM
$PSNL We just love dramatic daily drops!
0 · Reply
GGator
GGator Mar. 27 at 10:34 PM
$PSNL Hey, look around. Almost every stock is getting whacked. I know this sucks. The downside will be more pronounced here. But it will also be more pronounced on the other side if they continue executing when we come out of this. Just a thought. Have a great weekend all.
0 · Reply
magnitudeFC
magnitudeFC Mar. 27 at 8:02 PM
$PSNL Good news and data.. sounds about right for a 15% chop! https://x.com/PersonalisInc/status/2037612942628434274?s=20
1 · Reply
arribaStocktrading
arribaStocktrading Mar. 27 at 7:43 PM
$PSNL Sir, I'm tired of winning. Can we please stop winning so much!
2 · Reply
BioTechNoir
BioTechNoir Mar. 27 at 7:43 PM
$PSNL 50k ready if $5.XX
0 · Reply
LucienW
LucienW Mar. 27 at 7:23 PM
$PSNL I’m officially out of cash to add any more now…
0 · Reply
arribaStocktrading
arribaStocktrading Mar. 27 at 7:13 PM
$PSNL T Rowe Price right now:
1 · Reply
magnitudeFC
magnitudeFC Mar. 27 at 6:46 PM
$PSNL guys i was joking about IO getting denied.. did someone take it literally? wtf is going here
1 · Reply
LordBrypto
LordBrypto Mar. 27 at 5:36 PM
$PSNL reiumbersement denied
1 · Reply
Wax_Bean_futures
Wax_Bean_futures Mar. 27 at 5:06 PM
$PSNL this is getting painful
0 · Reply
magnitudeFC
magnitudeFC Mar. 27 at 4:55 PM
$PSNL just announce IO is delayed / denied and put us out of our misery
0 · Reply
LucienW
LucienW Mar. 27 at 3:34 PM
$PSNL added another few thousand shares… someone gotta stop me pleeeeease
0 · Reply
Wax_Bean_futures
Wax_Bean_futures Mar. 27 at 3:10 PM
$PSNL nibbled another 480 more shares. I assume Trump will put out a truth social post over the weekend, juicing the market.
1 · Reply
BioTechNoir
BioTechNoir Mar. 27 at 2:47 PM
$PSNL buying under 7
1 · Reply
arribaStocktrading
arribaStocktrading Mar. 27 at 2:42 PM
$PSNL This is an Ass Kicking ... get it?
0 · Reply
magnitudeFC
magnitudeFC Mar. 27 at 2:34 PM
$PSNL ugh hate to say it but money losing small cap biotech will be taken to the woodshed if this continues for much longer. Thank the lord they raised extra capital recently. I was such a vocal critic of that move, but in retrospect that may have been a company saving capital raise.
0 · Reply